Hereditary Haemorrhagic Telangiectasia: A Rare Disease As A Model for the Study of Human Atherosclerosis

By  

Current Pharmaceutical Design, Vol. 13, Iss. 36, 2007-12 ,pp. : 3656-3664

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: Molecular and Clinical Aspects of Hereditary Hemorragic Telangiectasia: A Rare Disease Executive Editor: (Emilo Jirillo)]

By  

Current Pharmaceutical Design, Vol. 12, Iss. 10, 2006-04 ,pp. : 1169-1170

Bentham Science Publishers

Access to resources Recommend Favorite

Involvement of the Transforming Growth Factor &bgr; in the Pathogenesis of Hereditary Hemorrhagic Telangiectasia

By  

Current Pharmaceutical Design, Vol. 12, Iss. 10, 2006-04 ,pp. : 1195-1200

Bentham Science Publishers

Access to resources Recommend Favorite

Ablation of T-Helper 1 Cell Derived Cytokines and of Monocyte-Derived Tumor Necrosis Factor- in Hereditary Hemorrhagic Telangiectasia: Immunological Consequences and Clinical Considerations

By  

Current Pharmaceutical Design, Vol. 12, Iss. 10, 2006-04 ,pp. : 1201-1208

Bentham Science Publishers

Access to resources Recommend Favorite

Hereditary Haemorrhagic Telangiectasia (HHT): Genetic and Molecular Aspects

By  

Current Pharmaceutical Design, Vol. 12, Iss. 10, 2006-04 ,pp. : 1173-1193

Bentham Science Publishers

Access to resources Recommend Favorite